We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Vertebral Balloon System Enables Targeted Placement

By HospiMedica International staff writers
Posted on 18 Feb 2014
A minimally invasive vertebral augmentation system treats vertebral compression fractures (VCFs), while also promoting patient safety.

The AVAflex Vertebral Balloon System combines a curved vertebral augmentation needle and a vertebral balloon to enable targeted balloon placement across the midline of the vertebral body, followed by targeted cement placement for optimal fill, all through a single pedicle. More...
The curved needle is made from nitinol, a superelastic composite made of nickel and titanium. The ultraflexible qualities of nitinol allow the curved augmentation needle to target hard to reach areas in the vertebral body, allowing maneuverability and flexibility in creating a cavity in the vertebral body prior to balloon insertion.

The AVAmax vertebral balloon, in turn, allows the surgeon to perform kyphoplasty in areas where a larger balloon might prohibit the procedure. Each catheter contains a durable balloon filled with a contrast agent to aid visualization when creating a void in the vertebral body, as well as clearly defined marker bands on the shaft to help identify correct advancement and placement. A digital pressure monitor at the tip of the inflation syringe helps to monitor pressure levels. At the touch of a button, balloon pressure can be shown in either atmospheres or PSI.

An important feature of the system is that it allows bilateral fracture reduction using a unilateral pediclular approach. Access kits and inflation syringes are packaged single and sterile, minimizing waste and improving operational efficiency. The AVAflex Vertebral Balloon System is a product of CareFusion (San Diego, CA, USA), and has been approved by the US Food and Drug Administration (FDA).

“The unipedicular approach offers a less risky approach to the midline of a vertebral body,” said Allan Brook, MD, an interventional radiologist with Montefiore Medical Center (New York, NY, USA). “Having another tool that places the cavity in the desired location can improve the effectiveness of vertebral augmentation in less time and with less radiation.”

Kyphoplasty uses a two-step process of inserting of a balloon device into the compacted vertebrae to attempt to restore the vertebrae to a more normal shape. Subsequently, a cement-like material is injected into the space created by the balloon to retain the correction. By restoring the vertebrae to a more normal state, alignment of the spine may be improved.

Related Links:

CareFusion



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Critical Care Conversion Kit
Adapter+
Infrared Digital Thermometer
R1B1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.